June 4, 2023

Volume XIII, Number 155


Laura A. Lydigsen

Laura is the chair of the firm’s appellate practice group. Her practice includes intellectual property litigation at both the district court and appellate level, with a focus on pharmaceuticals, biotechnology, and medical devices.

Laura has extensive experience in representing generic pharmaceutical companies in Hatch-Waxman pharmaceutical litigation. She has appeared in litigations and/or Patent Trial Appeal Board proceedings involving over a dozen different drug products and assisted clients with regulatory and pre-litigation strategy for many other drug products. She recognizes that a winning strategy in pharmaceutical litigation must be paired with good regulatory and business strategies and assists her clients in achieving all three.

Laura has been involved in all stages of appeals before the Federal Circuit across a wide range of technologies, including appeals involving pharmaceuticals, biotechnology, medical devices, automotive technology, and insurance. She has written briefs in dozens of Federal Circuit appeals, including complex multi-patent appeals stemming from decisions of the Patent Trial and Appeal Board (“PTAB”) in post-grant proceedings established under the America Invents Act. Laura also has experience representing pro bono a U.S. Veteran and a widow of a U.S. Veteran in appeals from adverse benefits decisions of the U.S. Court of Appeals for Veterans Claims.

Articles in the National Law Review database by Laura A. Lydigsen